WILL IMMUNOGENICITY LIMIT THE USE, EFFICACY, AND FUTURE-DEVELOPMENT OF THERAPEUTIC MONOCLONAL-ANTIBODIES

被引:131
作者
KUUSREICHEL, K [1 ]
GRAUER, LS [1 ]
KARAVODIN, LM [1 ]
KNOTT, C [1 ]
KRUSEMEIER, M [1 ]
KAY, NE [1 ]
机构
[1] UNIV KENTUCKY, COLL MED, LEXINGTON, KY 40506 USA
关键词
D O I
10.1128/CDLI.1.4.365-372.1994
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:365 / 372
页数:8
相关论文
共 83 条
[41]  
LORUSSO PM, 1991, P AM ASSOC CANC RES, V32, P1565
[42]  
MAGUIRE R, 1990, ANTIBODY IMMUNOCONJ, V3, P39
[43]   HUMAN-ANTIBODY RESPONSE TO THE INTRAVENOUS AND INTRAPERITONEAL ADMINISTRATION OF THE F(AB')2 FRAGMENT OF THE OC125 MURINE MONOCLONAL-ANTIBODY [J].
MAHER, VE ;
DRUKMAN, SJ ;
KINDERS, RJ ;
HUNTER, RE ;
JENNINGS, J ;
BRIGHAM, C ;
STEVENS, S ;
GRIFFIN, TW .
JOURNAL OF IMMUNOTHERAPY, 1992, 11 (01) :56-66
[44]   A CLINICAL-TRIAL OF ANTI-IDIOTYPE THERAPY FOR B-CELL MALIGNANCY [J].
MEEKER, TC ;
LOWDER, J ;
MALONEY, DG ;
MILLER, RA ;
THIELEMANS, K ;
WARNKE, R ;
LEVY, R .
BLOOD, 1985, 65 (06) :1349-1363
[45]  
MEREDITH RF, 1992, ANTIBODY IMMUNOCONJ, V5, P75
[46]  
MEREDITH RF, 1991, J NUCL MED, V32, P1162
[47]  
MEREDITH RF, 1993, ANTIBODY IMMUNOCONJ, V6, P39
[48]  
MURRAY JH, 1992, 2ND INT C HUM ANT HY, P6
[49]   HUMAN ANTIMURINE ANTIBODY-RESPONSES IN OVARIAN-CANCER PATIENTS UNDERGOING RADIOIMMUNOTHERAPY WITH THE MURINE MONOCLONAL-ANTIBODY OC-125 [J].
MUTO, MG ;
FINKLER, NJ ;
KASSIS, AI ;
LEPISTO, EM ;
KNAPP, RC .
GYNECOLOGIC ONCOLOGY, 1990, 38 (02) :244-248
[50]  
NISONOFF A, 1991, J IMMUNOL, V147, P2429